opical anti-inflammatories may be effective in keratoconus

While the etiology of keratoconus remains unclear, Albert Jun, MD, PhD, reviewed new research indicating that an inflammatory component can be measured in altered concentrations of inflammatory molecules such as IL 6, IL 10, TNF-alpha and matrix metalloproteinases.

This evidence may support the study of topical anti-inflammatory drops for treating and preventing disease advancement, he said at the symposium, which was jointly sponsored by Wilmer Eye Institute and the Maryland Optometric Association.

Posted in: Anti inflammatory, Keratoconus, Wilmer